Denali Therapeutics Stock Forecast - Simple Regression

DNLI Stock  USD 18.84  0.06  0.32%   
The Simple Regression forecasted value of Denali Therapeutics on the next trading day is expected to be 18.04 with a mean absolute deviation of 0.96 and the sum of the absolute errors of 58.50. Denali Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Denali Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 16th of January 2026 the rsi of Denali Therapeutics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Denali Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Denali Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Denali Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.77)
EPS Estimate Current Year
(3.01)
EPS Estimate Next Year
(2.97)
Wall Street Target Price
32.8571
EPS Estimate Current Quarter
(0.76)
Using Denali Therapeutics hype-based prediction, you can estimate the value of Denali Therapeutics from the perspective of Denali Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Denali Therapeutics using Denali Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Denali using crowd psychology based on the activity and movement of Denali Therapeutics' stock price.

Denali Therapeutics Short Interest

A significant increase or decrease in Denali Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Denali. Short interest can provide insight into the potential direction of Denali Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA
15.2054
Short Percent
0.1035
Short Ratio
8.69
Shares Short Prior Month
13.1 M
50 Day MA
17.369

Denali Therapeutics Hype to Price Pattern

Investor biases related to Denali Therapeutics' public news can be used to forecast risks associated with an investment in Denali. The trend in average sentiment can be used to explain how an investor holding Denali can time the market purely based on public headlines and social activities around Denali Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Denali Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Denali Therapeutics.

Denali Therapeutics Implied Volatility

    
  1.12  
Denali Therapeutics' implied volatility exposes the market's sentiment of Denali Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Denali Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Denali Therapeutics stock will not fluctuate a lot when Denali Therapeutics' options are near their expiration.
The Simple Regression forecasted value of Denali Therapeutics on the next trading day is expected to be 18.04 with a mean absolute deviation of 0.96 and the sum of the absolute errors of 58.50.

Denali Therapeutics after-hype prediction price

    
  USD 18.89  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Denali Therapeutics to cross-verify your projections.
For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.As of now, Denali Therapeutics' Receivables Turnover is increasing as compared to previous years. The Denali Therapeutics' current Asset Turnover is estimated to increase to 0.27, while Inventory Turnover is projected to decrease to (6.28). . The current Common Stock Shares Outstanding is estimated to decrease to about 96.2 M. The Denali Therapeutics' current Net Loss is estimated to increase to about (278.7 M).

Open Interest Against 2026-03-20 Denali Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Denali Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Denali Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Denali Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Denali Therapeutics' open interest, investors have to compare it to Denali Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Denali Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Denali. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Denali Therapeutics Additional Predictive Modules

Most predictive techniques to examine Denali price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Denali using various technical indicators. When you analyze Denali charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Simple Regression model is a single variable regression model that attempts to put a straight line through Denali Therapeutics price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

Denali Therapeutics Simple Regression Price Forecast For the 17th of January 2026

Given 90 days horizon, the Simple Regression forecasted value of Denali Therapeutics on the next trading day is expected to be 18.04 with a mean absolute deviation of 0.96, mean absolute percentage error of 1.46, and the sum of the absolute errors of 58.50.
Please note that although there have been many attempts to predict Denali Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Denali Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Denali Therapeutics Stock Forecast Pattern

Backtest Denali TherapeuticsDenali Therapeutics Price PredictionBuy or Sell Advice 

Denali Therapeutics Forecasted Value

In the context of forecasting Denali Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Denali Therapeutics' downside and upside margins for the forecasting period are 14.40 and 21.69, respectively. We have considered Denali Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
18.84
18.04
Expected Value
21.69
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Denali Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Denali Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria118.489
BiasArithmetic mean of the errors None
MADMean absolute deviation0.9591
MAPEMean absolute percentage error0.0553
SAESum of the absolute errors58.5022
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as Denali Therapeutics historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for Denali Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Denali Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
15.2518.8922.53
Details
Intrinsic
Valuation
LowRealHigh
18.4822.1225.76
Details
19 Analysts
Consensus
LowTargetHigh
29.9032.8636.47
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.82-0.77-0.73
Details

Other Forecasting Options for Denali Therapeutics

For every potential investor in Denali, whether a beginner or expert, Denali Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Denali Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Denali. Basic forecasting techniques help filter out the noise by identifying Denali Therapeutics' price trends.

Denali Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Denali Therapeutics stock to make a market-neutral strategy. Peer analysis of Denali Therapeutics could also be used in its relative valuation, which is a method of valuing Denali Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Denali Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Denali Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Denali Therapeutics' current price.

Denali Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Denali Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Denali Therapeutics shares will generate the highest return on investment. By undertsting and applying Denali Therapeutics stock market strength indicators, traders can identify Denali Therapeutics entry and exit signals to maximize returns.

Denali Therapeutics Risk Indicators

The analysis of Denali Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Denali Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting denali stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether Denali Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Denali Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Denali Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Denali Therapeutics Stock:
Check out Historical Fundamental Analysis of Denali Therapeutics to cross-verify your projections.
For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Denali Therapeutics. If investors know Denali will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.92)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.27)
Return On Equity
(0.44)
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Denali Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Denali Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Denali Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.